Literature DB >> 30228931

Subgroup-specific immune and stromal microenvironment in medulloblastoma.

Michael Bockmayr1,2,3, Malte Mohme4, Frederick Klauschen2, Beate Winkler1, Jan Budczies2, Stefan Rutkowski1, Ulrich Schüller1,3,5.   

Abstract

Knowledge on immune and stromal cells in medulloblastoma microenvironment is still limited as previous work was frequently restricted by low sample size and the lack of molecular subgroup information. We characterized 10 microenvironment cell populations as well as PD-L1 from gene expression in 1422 brain tumors and 763 medulloblastomas. All in all, medulloblastomas showed low expression of immune markers. Still, there were substantial differences with a clustering of medulloblastoma subgroups according to their microenvironment profile. Specifically, SHH medulloblastomas displayed strong signatures of fibroblasts, T cells and macrophages, while markers of cytotoxic lymphocytes were enriched in Group 4 tumors. PD-L1 gene expression appeared to be relatively high in single SHH and WNT cases but was undetectable by immunohistochemistry. In addition, two diverse immuno-stromal patterns were identified, indicating distinct types of local tumor immunosuppression, which were primarily controlled by either macrophage and regulatory T cell-mediated mechanisms or immunosuppressive cytokines and checkpoints, respectively. None of the immune cell signatures had an independent prognostic value in the present dataset after multiple testing correction. These results suggest a mild, but subgroup-specific infiltration of immune cells in medulloblastoma.

Entities:  

Keywords:  PD-L1, stroma; gene expression; immune system; medulloblastoma; microenvironment

Year:  2018        PMID: 30228931      PMCID: PMC6140816          DOI: 10.1080/2162402X.2018.1462430

Source DB:  PubMed          Journal:  Oncoimmunology        ISSN: 2162-4011            Impact factor:   8.110


  46 in total

1.  Immune heterogeneity of glioblastoma subtypes: extrapolation from the cancer genome atlas.

Authors:  Tiffany Doucette; Ganesh Rao; Arvind Rao; Li Shen; Kenneth Aldape; Jun Wei; Kristine Dziurzynski; Mark Gilbert; Amy B Heimberger
Journal:  Cancer Immunol Res       Date:  2013-08       Impact factor: 11.151

2.  The therapeutic potential of natural killer cells to target medulloblastoma.

Authors:  Antonio Pérez-Martínez; Lucia Fernández; Miguel Angel Díaz
Journal:  Expert Rev Anticancer Ther       Date:  2016-05-17       Impact factor: 4.512

3.  Control of inflammation by stromal Hedgehog pathway activation restrains colitis.

Authors:  John J Lee; Michael E Rothenberg; E Scott Seeley; Bryan Zimdahl; Sally Kawano; Wan-Jin Lu; Kunyoo Shin; Tomoyo Sakata-Kato; James K Chen; Maximilian Diehn; Michael F Clarke; Philip A Beachy
Journal:  Proc Natl Acad Sci U S A       Date:  2016-11-04       Impact factor: 11.205

4.  Differential Immune Microenvironments and Response to Immune Checkpoint Blockade among Molecular Subtypes of Murine Medulloblastoma.

Authors:  Christina D Pham; Catherine Flores; Changlin Yang; Elaine M Pinheiro; Jennifer H Yearley; Elias J Sayour; Yanxin Pei; Colin Moore; Roger E McLendon; Jianping Huang; John H Sampson; Robert Wechsler-Reya; Duane A Mitchell
Journal:  Clin Cancer Res       Date:  2015-09-24       Impact factor: 12.531

Review 5.  The Microenvironmental Landscape of Brain Tumors.

Authors:  Daniela F Quail; Johanna A Joyce
Journal:  Cancer Cell       Date:  2017-03-13       Impact factor: 31.743

6.  Assessment of programmed death-ligand 1 expression and tumor-associated immune cells in pediatric cancer tissues.

Authors:  Robbie G Majzner; Jason S Simon; Joseph F Grosso; Daniel Martinez; Bruce R Pawel; Mariarita Santi; Melinda S Merchant; Birgit Geoerger; Imene Hezam; Virginie Marty; Phillippe Vielh; Mads Daugaard; Poul H Sorensen; Crystal L Mackall; John M Maris
Journal:  Cancer       Date:  2017-06-13       Impact factor: 6.860

7.  Intertumoral Heterogeneity within Medulloblastoma Subgroups.

Authors:  Florence M G Cavalli; Marc Remke; Ladislav Rampasek; John Peacock; David J H Shih; Betty Luu; Livia Garzia; Jonathon Torchia; Carolina Nor; A Sorana Morrissy; Sameer Agnihotri; Yuan Yao Thompson; Claudia M Kuzan-Fischer; Hamza Farooq; Keren Isaev; Craig Daniels; Byung-Kyu Cho; Seung-Ki Kim; Kyu-Chang Wang; Ji Yeoun Lee; Wieslawa A Grajkowska; Marta Perek-Polnik; Alexandre Vasiljevic; Cecile Faure-Conter; Anne Jouvet; Caterina Giannini; Amulya A Nageswara Rao; Kay Ka Wai Li; Ho-Keung Ng; Charles G Eberhart; Ian F Pollack; Ronald L Hamilton; G Yancey Gillespie; James M Olson; Sarah Leary; William A Weiss; Boleslaw Lach; Lola B Chambless; Reid C Thompson; Michael K Cooper; Rajeev Vibhakar; Peter Hauser; Marie-Lise C van Veelen; Johan M Kros; Pim J French; Young Shin Ra; Toshihiro Kumabe; Enrique López-Aguilar; Karel Zitterbart; Jaroslav Sterba; Gaetano Finocchiaro; Maura Massimino; Erwin G Van Meir; Satoru Osuka; Tomoko Shofuda; Almos Klekner; Massimo Zollo; Jeffrey R Leonard; Joshua B Rubin; Nada Jabado; Steffen Albrecht; Jaume Mora; Timothy E Van Meter; Shin Jung; Andrew S Moore; Andrew R Hallahan; Jennifer A Chan; Daniela P C Tirapelli; Carlos G Carlotti; Maryam Fouladi; José Pimentel; Claudia C Faria; Ali G Saad; Luca Massimi; Linda M Liau; Helen Wheeler; Hideo Nakamura; Samer K Elbabaa; Mario Perezpeña-Diazconti; Fernando Chico Ponce de León; Shenandoah Robinson; Michal Zapotocky; Alvaro Lassaletta; Annie Huang; Cynthia E Hawkins; Uri Tabori; Eric Bouffet; Ute Bartels; Peter B Dirks; James T Rutka; Gary D Bader; Jüri Reimand; Anna Goldenberg; Vijay Ramaswamy; Michael D Taylor
Journal:  Cancer Cell       Date:  2017-06-12       Impact factor: 31.743

8.  TH1 predominance is associated with improved survival in pediatric medulloblastoma patients.

Authors:  Verena Wiegering; Matthias Eyrich; Stefan Rutkowski; Matthias Wölfl; Paul G Schlegel; Beate Winkler
Journal:  Cancer Immunol Immunother       Date:  2011-02-16       Impact factor: 6.968

Review 9.  Risk stratification of childhood medulloblastoma in the molecular era: the current consensus.

Authors:  Vijay Ramaswamy; Marc Remke; Eric Bouffet; Simon Bailey; Steven C Clifford; Francois Doz; Marcel Kool; Christelle Dufour; Gilles Vassal; Till Milde; Olaf Witt; Katja von Hoff; Torsten Pietsch; Paul A Northcott; Amar Gajjar; Giles W Robinson; Laetitia Padovani; Nicolas André; Maura Massimino; Barry Pizer; Roger Packer; Stefan Rutkowski; Stefan M Pfister; Michael D Taylor; Scott L Pomeroy
Journal:  Acta Neuropathol       Date:  2016-04-04       Impact factor: 17.088

10.  Molecular subgroups of medulloblastoma: the current consensus.

Authors:  Michael D Taylor; Paul A Northcott; Andrey Korshunov; Marc Remke; Yoon-Jae Cho; Steven C Clifford; Charles G Eberhart; D Williams Parsons; Stefan Rutkowski; Amar Gajjar; David W Ellison; Peter Lichter; Richard J Gilbertson; Scott L Pomeroy; Marcel Kool; Stefan M Pfister
Journal:  Acta Neuropathol       Date:  2011-12-02       Impact factor: 17.088

View more
  31 in total

Review 1.  Updates on Management of Adult Medulloblastoma.

Authors:  Nazanin Majd; Marta Penas-Prado
Journal:  Curr Treat Options Oncol       Date:  2019-06-24

2.  High expression of Toll-like receptor 7 is a survival factor in pediatric medulloblastoma.

Authors:  Lourdes Alvarez-Arellano; Pilar Eguía-Aguilar; Patricia Piña-Sánchez; Nadia González-García; Alam Palma-Guzman; Mario Perezpeña-Diazconti; Carmen Maldonado-Bernal
Journal:  Childs Nerv Syst       Date:  2021-09-04       Impact factor: 1.475

3.  Tumor-Associated Macrophages Correlate With Prognosis in Medulloblastoma.

Authors:  Jin Zhang; Xia Yuan; Yuan Wang; Jingjing Liu; Zhigang Li; Shuting Li; Yan Liu; Xiaojun Gong; Yanling Sun; Wanshui Wu; Liming Sun; Shuxu Du; Tianyou Wang
Journal:  Front Oncol       Date:  2022-07-04       Impact factor: 5.738

4.  An extracellular vesicle-related gene expression signature identifies high-risk patients in medulloblastoma.

Authors:  Thomas K Albert; Marta Interlandi; Martin Sill; Monika Graf; Natalia Moreno; Kerstin Menck; Astrid Rohlmann; Viktoria Melcher; Sonja Korbanka; Gerd Meyer Zu Hörste; Tobias Lautwein; Michael C Frühwald; Christian F Krebs; Dörthe Holdhof; Melanie Schoof; Annalen Bleckmann; Markus Missler; Martin Dugas; Ulrich Schüller; Natalie Jäger; Stefan M Pfister; Kornelius Kerl
Journal:  Neuro Oncol       Date:  2021-04-12       Impact factor: 12.300

Review 5.  Immunotherapy for pediatric brain tumors: past and present.

Authors:  Jessica B Foster; Peter J Madsen; Meenakshi Hegde; Nabil Ahmed; Kristina A Cole; John M Maris; Adam C Resnick; Phillip B Storm; Angela J Waanders
Journal:  Neuro Oncol       Date:  2019-10-09       Impact factor: 12.300

6.  Histone demethylase UTX/KDM6A enhances tumor immune cell recruitment, promotes differentiation and suppresses medulloblastoma.

Authors:  Jiaqing Yi; Xuanming Shi; Zhenyu Xuan; Jiang Wu
Journal:  Cancer Lett       Date:  2020-11-27       Impact factor: 8.679

Review 7.  Immunosuppression in Medulloblastoma: Insights into Cancer Immunity and Immunotherapy.

Authors:  Zahraa F Audi; Zahraa Saker; Mahdi Rizk; Hisham F Bahmad; Sanaa M Nabha; Hayat Harati; Youssef Fares
Journal:  Curr Treat Options Oncol       Date:  2021-07-30

Review 8.  Multifaceted microglia - key players in primary brain tumour heterogeneity.

Authors:  Lily Keane; Mathilde Cheray; Klas Blomgren; Bertrand Joseph
Journal:  Nat Rev Neurol       Date:  2021-03-10       Impact factor: 42.937

9.  DIMEimmune: Robust estimation of infiltrating lymphocytes in CNS tumors from DNA methylation profiles.

Authors:  Sepehr Safaei; Malte Mohme; Judith Niesen; Ulrich Schüller; Michael Bockmayr
Journal:  Oncoimmunology       Date:  2021-06-17       Impact factor: 8.110

Review 10.  Neuropilin-1: A Key Protein to Consider in the Progression of Pediatric Brain Tumors.

Authors:  Manon Douyère; Pascal Chastagner; Cédric Boura
Journal:  Front Oncol       Date:  2021-07-01       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.